π΅οΈ Biocryst Pharmaceuticals Inc ($BCRX)
SEC insider & ownership activity, last 12 months Β· CIK 882796 Β· every row links its SEC filing
Over the last 12 months insiders sold $4.7M with no open-market buying against it. Alane P. Barnes sold $3.5M through a program of 7 sale notices averaging $494K (DecβMay). No red-flag 8-Ks in the window.
π¨ 5 signals active β
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) Β· 4 sellers, $4.7M (11 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Alane P. Barnes | 0 | β | 7 | $3.5M | May 13, 2026 |
| Heggie Theresa | 0 | β | 2 | $1.1M | Mar 20, 2026 |
| Amy E. McKee | 0 | β | 1 | $100K | May 18, 2026 |
| Sanders Machelle | 0 | β | 1 | $69K | Nov 13, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 8.4% | 13G | Apr 17, 2025 | filing β | |
| RA Capital Management, L.P. | 7.3% | 13G | Nov 12, 2025 | filing β | |
| Peter Kolchinsky | 7.3% | 13G | Nov 12, 2025 | filing β | |
| Rajeev Shah | 7.3% | 13G | Nov 12, 2025 | filing β | |
| RA Capital Healthcare Fund, L.P. | 7.3% | 13G | Nov 12, 2025 | filing β | |
| Deerfield MGMT, L.P. | 6.8% | 13G | Feb 12, 2026 | filing β | |
| Deerfield Management Company, L.P. | 6.8% | 13G | Feb 12, 2026 | filing β | |
| Deerfield Partners, L.P. | 6.8% | 13G | Feb 12, 2026 | filing β | |
| James E. Flynn | 6.8% | 13G | Feb 12, 2026 | filing β | |
| Vanguard Capital Management | 5.2% | 13G | Apr 29, 2026 | filing β |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Amy McKee | $100K | May 18, 2026 | filing β |
| Alane P. Barnes | $596K | May 13, 2026 | filing β |
| Heggie Theresa | $505K | Mar 20, 2026 | filing β |
| Alane P. Barnes | $1.4M | Mar 16, 2026 | filing β |
| Jon P. Stonehouse | $2.6M | Mar 2, 2026 | filing β |
| Alane P. Barnes | $167K | Dec 22, 2025 | filing β |
| Alane P. Barnes | $162K | Dec 15, 2025 | filing β |
| Alane P. Barnes | $151K | Dec 3, 2025 | filing β |
| Alane P. Barnes | $367K | Dec 2, 2025 | filing β |
| Alane P. Barnes | $644K | Dec 1, 2025 | filing β |
| Helen M Thackray | $328K | Nov 25, 2025 | filing β |
| Helen Thackray | $308K | Nov 21, 2025 | filing β |
| Sanders Machelle | $69K | Nov 13, 2025 | filing β |
| Heggie Theresa | $596K | Aug 13, 2025 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Exit or disposal costs (2.05) | Jun 25, 2026 | filing β |
| Reg FD disclosure (7.01) | Jun 25, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jun 25, 2026 | filing β |
| Officer/director changes (5.02) | Jun 11, 2026 | filing β |
| Shareholder vote (5.07) | Jun 11, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing β |
| Earnings (2.02) | May 6, 2026 | filing β |
| Reg FD disclosure (7.01) | May 6, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing β |
| Reg FD disclosure (7.01) | May 4, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing β |
| Earnings (2.02) | Feb 26, 2026 | filing β |
| Reg FD disclosure (7.01) | Feb 26, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing β |
| Material agreement (1.01) | Jan 23, 2026 | filing β |
| Acquisition or disposition (2.01) | Jan 23, 2026 | filing β |
| New financial obligation (2.03) | Jan 23, 2026 | filing β |
| Reg FD disclosure (7.01) | Jan 23, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jan 23, 2026 | filing β |
| Earnings (2.02) | Jan 12, 2026 | filing β |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing β |
| Other events (8.01) | Jan 12, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing β |
| Reg FD disclosure (7.01) | Jan 9, 2026 | filing β |
| Other events (8.01) | Dec 12, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Dec 12, 2025 | filing β |
| Officer/director changes (5.02) | Dec 9, 2025 | filing β |
| Other events (8.01) | Dec 3, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Dec 3, 2025 | filing β |
| Earnings (2.02) | Nov 3, 2025 | filing β |